A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
Open Access
- 15 April 1999
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 13 (8) , 1025-1036
- https://doi.org/10.1101/gad.13.8.1025
Abstract
The molecular mechanisms controlling bone extracellular matrix (ECM) deposition by differentiated osteoblasts in postnatal life, called hereafter bone formation, are unknown. This contrasts with the growing knowledge about the genetic control of osteoblast differentiation during embryonic development. Cbfa1, a transcriptional activator of osteoblast differentiation during embryonic development, is also expressed in differentiated osteoblasts postnatally. The perinatal lethality occurring in Cbfa1-deficient mice has prevented so far the study of its function after birth. To determine if Cbfa1 plays a role during bone formation we generated transgenic mice overexpressing Cbfa1 DNA-binding domain (ΔCbfa1) in differentiated osteoblasts only postnatally. ΔCbfa1 has a higher affinity for DNA than Cbfa1 itself, has no transcriptional activity on its own, and can act in a dominant-negative manner in DNA cotransfection assays. ΔCbfa1-expressing mice have a normal skeleton at birth but develop an osteopenic phenotype thereafter. Dynamic histomorphometric studies show that this phenotype is caused by a major decrease in the bone formation rate in the face of a normal number of osteoblasts thus indicating that once osteoblasts are differentiated Cbfa1 regulates their function. Molecular analyses reveal that the expression of the genes expressed in osteoblasts and encoding bone ECM proteins is nearly abolished in transgenic mice, and ex vivo assays demonstrated that ΔCbfa1-expressing osteoblasts were less active than wild-type osteoblasts. We also show that Cbfa1 regulates positively the activity of its own promoter, which has the highest affinity Cbfa1-binding sites characterized. This study demonstrates that beyond its differentiation function Cbfa1 is the first transcriptional activator of bone formation identified to date and illustrates that developmentally important genes control physiological processes postnatally.Keywords
This publication has 45 references indexed in Scilit:
- Functional Hierarchy between Two OSE2 Elements in the Control of Osteocalcin Gene Expression in VivoJournal of Biological Chemistry, 1998
- Mice Lacking Osteopontin Show Normal Development and Bone Structure but Display Altered Osteoclast Formation In VitroJournal of Bone and Mineral Research, 1998
- Two Domains Unique to Osteoblast-Specific Transcription Factor Osf2/Cbfa1 Contribute to Its Transactivation Function and Its Inability To Heterodimerize with CbfβMolecular and Cellular Biology, 1998
- A Xenopus homologue of aml-1 reveals unexpected patterning mechanisms leading to the formation of embryonic bloodDevelopment, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLProceedings of the National Academy of Sciences, 1998
- Heritable Diseases of CollagenNew England Journal of Medicine, 1984
- Dynamic histomorphometry of alveolar bone remodeling in the adult ratThe Anatomical Record, 1980
- Limb development in mouse embryos. I. Analysis of teratogenic effects of retinoic acidTeratology, 1973
- MUTATIONAL DYSOSTOSIS (CLEIDOCRANIAL-DYSOSTOSIS)1946